Can a Blue Dye Help You Live Longer? The internet says yes, as TikTokers coat their tongues in a bright blue dye they claim boosts longevity at the cellular level. But the anti-aging properties of methylene blue (MB) are far from being confirmed by the scientific community, and researchers are urging caution because the science is still in its early stages and much more needs to be known.

From Malaria to Modernity

Methylene blue may be new to you, but it’s been known in the medical world for more than a century. First created in 1876 by Heinrich Caro, a chemist at German multinational chemical company BASF, the synthetic phenothiazine dye was initially developed as a colorant for textiles. Scientists discovered its biological usefulness, and by 1891 Paul Ehrlich was using MB to treat malaria – marking the start of chemotherapy. Since then, MB has been used as a surgical stain and, with FDA approval, to treat conditions including methemoglobinemia. It has also been used in certain medical contexts involving cyanide poisoning and ifosfamide-associated encephalopathy. MB’s small molecular size allows rapid tissue penetration, and it can be reduced to leucomethylene blue (leucoMB), which can act as an antioxidant.

More recently, longevity researchers are looking closely at certain MB properties that could make it a promising anti-aging agent:

It appears that MB can swap electrons like a “tiny battery charger,” bypassing damaged parts of the mitochondrial electron transport chain and possibly reducing free radical production and keeping cells running more efficiently. Because aging is closely linked to mitochondrial dysfunction and oxidative stress, researchers are increasingly looking at the possibility of using MB to support cell health and promote healthy aging.

Social Media vs. Scientific Rigor

It’s hard to overlook MB while scrolling through wellness podcasts or social media. Influencers and biohackers claim it “cures brain fog,” boosts energy, and slows aging. MB lozenges, pills, and vivid blue drops, the influencers say, are the latest answer to healthy aging.

Exploring the possible role of MB in cognitive enhancement and longevity applications involves more than just social media followers. For MB to take its place among treatments intended to slow the aging process and enhance healthspan, the scientific evidence needs to be established through rigorous research and testing. Let’s look at why longevity researchers show interest in MB and where their studies are headed.

Right now, the excitement appears to be getting ahead of the evidence. Current claims about MB’s positive effects on aging are based largely on preliminary laboratory studies and limited human evidence rather than large-scale clinical trials. “In the race to see who can live the longest and healthiest, OTC compounds like methylene blue often gain intense attention,” health writer Leslie Goldman, MPH, points out in Harvard Medical School’s Special Health Report, Pathways to Longevity. “But they should also engender intense scrutiny.”

That scrutiny is underway.

Research on MB’s impact on the brain is still in its early stages, but in rodent models of dementia, MB improved memory and learning. It also reduced protein clumps and cell damage in Alzheimer’s and stroke models, while another study showed stronger connectivity in memory-related brain networks.

A systematic review of the clinical effectiveness and prospects of methylene blue from the Korea Institute of Science and Technology (KIST) focused on clinical trials of MB-based therapies applied to brain diseases, cancer imaging and diagnosis, infectious diseases such as malaria or COVID-19, and cardiovascular diseases.

Human studies tend to be much smaller, and evidence is limited. One randomized, double-blind, placebo-controlled study in 26 healthy adults found that a single low dose of MB was associated with a 7% improvement in memory retrieval and increased activity in brain regions involved in memory on fMRI scans.

These results are interesting, but they haven’t yet proven that MB slows aging or prevents cognitive decline in humans.

Safety and Clinical Considerations

While MB has established medical uses, its potential use for longevity and cognitive enhancement remains investigational. Safety and dosing are important considerations, particularly because the concentrations and formulations promoted online may differ from those used in medical settings.

Methylene blue can pose serious risks for people with glucose-6-phosphate dehydrogenase (G6PD) deficiency and can interact with serotonergic medications, potentially increasing the risk of serotonin syndrome. These considerations highlight the importance of distinguishing medically supervised use from consumer use of MB products marketed for wellness or longevity.

For clinicians, the question is not simply whether MB has interesting biological properties, but also whether its potential benefits can be demonstrated at doses and with formulations that are safe, effective, and clinically meaningful.

Concluding Thoughts

MB isn’t new, but the social media excitement around it has made it seem like the “next big thing” in healthy aging and longevity. Because it’s a well-known pharmaceutical compound that’s already FDA-approved for certain medical uses, researchers are continuing to explore whether its biological effects could have applications in cell health, cognitive function, and healthy aging. The potential of MB therapy and its impact on healthspan can only be determined through further research that establishes its safety and efficacy in humans.

Sources:

The Potentials of Methylene Blue as an Anti-Aging Drug

What to Know About Methylene Blue

Methylene Blue Anti-Aging: Hype vs Evidence

Can Methylene Blue Support Anti-Aging? Science vs. Hype

Methylene Blue and Cancer: Evidence & Mechanisms

Clinical Effectiveness and Prospects of Methylene Blue: A Systematic Review